midazolam has been researched along with Toxemia in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Toxemia: A condition produced by the presence of toxins or other harmful substances in the BLOOD.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, D | 1 |
Boelke, E | 1 |
Stanescu, A | 1 |
Buttenschoen, K | 1 |
Vasilescu, C | 1 |
Seidelmann, M | 1 |
Beger, HG | 1 |
1 trial available for midazolam and Toxemia
Article | Year |
---|---|
Endotoxemia and mediator release during colonoscopy.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Toxins; C-Reactive Protein; Colonoscopy; Endotoxins; Enzym | 1995 |